Medigard Limited announced earnings results for the year ended on June 30, 2018. For the period, the company’s revenue was AUD 36,693 as compared to AUD 65,295 a year ago. Loss before income tax expense was AUD 614,648 as compared to AUD 122,690 a year ago. Net loss for the year after income tax expense was AUD 614,648 as compared to AUD 122,690 a year ago. Basic and diluted loss per share was 0.58 cents as compared to 0.13 cents a year ago. Net cash used in operating activities was AUD 299,445 as compared to AUD 188,084 a year ago.